Entries by Melissa Gillespie

Conducting Clinical Trials in Latin America

In today’s competitive landscape speed is key in getting a drug from discovery through to market. Everything that speeds up the clinical trials process (without sacrificing safety and quality) is a priority to today’s drug developers because it is essential in shortening a product’s time to market. Clinical trials across multiple regions of the world […]

Clinical Innovation and Partnering World

Welocalize Life Sciences is attending Clinical Innovation and Partnering World on March 8 + 9, 2017 in London. Clinical Innovation and Partnering World is one of the most established and valuable conferences for the pharmaceutical and biotech community. Over recent years, there has been significant discussion about the challenges facing pharma and the resulting need […]

The Price of Translation

What is involved in the translation process? To do it right, a lot more than you may think—from working with subject matter experts to ensuring messages resonate in local markets.

The team at Welocalize Life Sciences offers these tips for understanding the true cost of translation and why creative, technical and highly regulated industries may require additional steps and expertise in the translation process.

eyeforpharma

Join Welocalize Life Sciences at Europe’s largest commercial pharma meeting of 1000+ industry leaders focused on commercial innovation, customer centricity and patient engagement. For 2017 eyeforpharma has enlisted a brand new faculty of C-suite industry leaders, a completely redesigned agenda and invited innovative tech companies and stakeholders to ensure pharma can truly become integral to […]

Communicate with Patients via Interpretation Services

People who are not proficient in the language of the country in which they live may have difficulty accessing health services. They may need access to medical interpreters and translated information when they visit a healthcare provider. The large number of languages spoken in certain cities and countries can make provision of translation and interpretation […]

The Art and Science of Translating Regulated Content

To comply with laws and ensure that patients get the right treatment for their ailments, pharmaceutical, biotechnology and healthcare organizations must manage high volumes of content. They must keep all published information correct, current, and consistent across publications, packaging, websites and marketing materials. This is difficult enough to manage in just one language, but gets […]

Language Barriers in End-of-Life Care

The population in the United States is growing older and more ethnically diverse over time, according to United States Census Bureau statistics. This means more medical resources will be devoted to end-of-life care (EoLC). Language barriers can often create additional costs and cause inefficiencies in EoLC. Studies show some patients from different ethnic groups are […]

DIA EuroMeeting

The top regulators, clinical, safety and research professionals in healthcare and drug development convene at DIA EuroMeeting 2017 in Glasgow, UK. Meet Welocalize Life Sciences at DIA EuroMeeting to discuss best practices on the important role that language solutions and translation plays in clinical trials, patient recruitment and regulatory affairs material and documentation. Welocalize Life […]

Welocalize Launches Dedicated Life Sciences Division

Frederick, Maryland – January 31, 2017 – Welocalize, global leader in innovative translation and localization solutions, announces the formation of Welocalize Life Sciences, a division that brings together the recent Welocalize acquisitions of Global Language Solutions (GLS) and Nova Language Services (Nova). The merged entities represent more than two decades of experience in specialized language […]